Latest filing published 19 Mar 2018 for CanniMed Therapeutics Inc., €20.1M.
Apex Investment Limited Partnership appears in our data through filings on CanniMed Therapeutics Inc. shares, published by SEDI. We count 4 filings; the first trade dates from 21 December 2016 and the latest from 15 March 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 19 March 2018, reports a transaction of €20.1M in CanniMed Therapeutics Inc. The median gap between a trade and its publication by SEDI is 6 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations